How Will The Oral Solid Dosage Pharmaceutical Formulation Market Reach $810.94 Billion By 2029 Amid Global Shifts?
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Is The Projected Valuation Of The Oral Solid Dosage Pharmaceutical Formulation Market In The Coming Years?
In recent times, the market size for oral solid dosage pharmaceutical formulations has significantly expanded. It is projected to rise from $618.34 billion in 2024 to $653.26 billion in 2025, boasting a compound annual growth rate (CAGR) of 5.6%. This growth during the historical period can be linked to factors such as the prevalence of chronic diseases, an aging populace, expanded access to healthcare, the promotion of generic formulations, and a shift in consumer preferences.
The market size for oral solid dosage pharmaceutical formulations is predicted to witness a notable rise in the forthcoming years, expected to increase to “$810.94 billion by 2029” with a compound annual growth rate (CAGR) of 5.6%. This growth in the estimation period can be traced back to the demand for personalized medicine, adoption of controlled-release, focus on biopharmaceutical, expansion in emerging markets, and alterations in policies and reimbursements. The forecast period is also expected to be characterized by critical trends such as the uptake of personalized medicine, integration of digital health, emergence of telemedicine services, emphasis on preventive healthcare, and the ongoing integration of artificial intelligence in healthcare.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15626&type=smp
What Drivers Are Accelerating Expansion Of The Oral Solid Dosage Pharmaceutical Formulation Market?
The rising incidence of chronic diseases, which include prolonged health conditions lasting three months or more, is projected to accelerate the expansion of the oral solid dosage pharmaceutical formulation market. The surge in chronic disorders can be attributed to elements such as increasing age groups, inactive lifestyles, inadequate dietary practices, environmental conditions, alongside advancements in identification and diagnostic techniques. Oral solid dosage forms play an indispensable role in the management of chronic conditions, promoting enduring treatment compliance due to their convenience, stability, and accuracy in dosage. For example, the World Health Organization, a Switzerland-based intergovernmental organization, forecasted in February 2024 that over 35 million fresh cancer cases would be reported by 2050, indicating a 77% augmentation in comparison to the projected 20 million cases in 2022. Thus, the escalating incidence of chronic disorders is propelling the growth of the oral solid dosage pharmaceutical formulation market.
How Does The Oral Solid Dosage Pharmaceutical Formulation Market Differ By Segment?
The oral solid dosage pharmaceutical formulation market covered in this report is segmented –
1) By Dosage Form: Tablets, Capsules, Powders And Granules, Lozenges And Pastilles, Gummies
2) By Mechanism: Controlled-Release, Immediate-Release, Delayed-Release
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies, Hypermarkets Or Supermarkets
4) By End-User: Large-Size Companies, Medium And Small-Size Companies, Other End-Users
Subsegments:
1) By Tablets: Immediate-Release Tablets, Extended-Release Tablets, Controlled-Release Tablets, Effervescent Tablets, Chewable Tablets, Sublingual Tablets
2) By Capsules: Hard Gelatin Capsules, Soft Gel Capsules, Liquid-Filled Capsules, Delayed-Release Capsules
3) By Powders And Granules: Oral Powders (Reconstitution), Granules (Oral Suspension Or Dispersible Granules)
4) By Lozenges And Pastilles: Medicinal Lozenges, Herbal Lozenges, Sugar-Free Lozenges, Pastilles ( Throat Or Cough Relief)
5) By Gummies: Vitamin Gummies, Herbal And Nutritional Supplement Gummies, Pharmaceutical Gummies ( Pain Relief Or Sleep Aids)
What New Opportunities Are Emerging From Trends In The Oral Solid Dosage Pharmaceutical Formulation Market?
The oral solid dosage pharmaceutical formulation market is characterized by major companies innovating with products such as liquid-filled capsules. These products aim to enhance drug delivery, improve absorption rates, and provide patients with convenient dosing options. Liquid-filled capsules are made up of a gelatin shell that holds a liquid or semi-solid formulation filled with active pharmaceutical ingredients (APIs) and fillers. For example, in July 2023, Zeon Lifesciences Ltd., a pharmaceutical firm based in India, introduced their liquid-filled capsules. These capsules offer an improved delivery system characterized by heightened absorption rates and bioavailability. They ensure optimal levels of active ingredients are delivered for immediate results and maximum efficacy. Zeon’s liquid-filled capsules provide accurate, consistent dosages that enhance patient adherence and control over medication administration. Using advanced technologies, these capsules enhance bioavailability, protect the medication’s integrity and improve patient outcomes. As a practical, effective, and trustworthy alternative to traditional dosage forms, Zeon’s liquid-filled capsules are establishing a new benchmark in patient care and compliance within the pharmaceutical industry.
Who Are The Global Leaders Steering The Oral Solid Dosage Pharmaceutical Formulation Market Forward?
Major companies operating in the oral solid dosage pharmaceutical formulation market are Pfizer Inc., Johnson & Johnson, Merck & Co. Inc., AbbVie Inc., Bayer AG, Bristol-Myers Squibb Company, AstraZeneca Plc., Novartis AG, Hoffman-La-Roche Ltd., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Boehringer Ingelheim GmbH, Gilead Sciences, Amgen Inc., Teva Pharmaceuticals, Otsuka Pharmaceutical Co. Ltd., Astellas Pharma Inc., Biogen Inc., Lonza Group, Catalent Inc., Ashland Inc., Piramal Pharma Solutions, Jubilant Pharmova, CordenPharma International
Access The Complete Report Here:
Which Region Is Likely To Register The Fastest Growth In The Oral Solid Dosage Pharmaceutical Formulation Market?
North America was the largest region in the oral solid dosage pharmaceutical formulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral solid dosage pharmaceutical formulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15626&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
